Avoca signs astaxanthin agreement with Synthetic Genomics
date:Jun 25, 2014
I has developed a process for production of natural astaxanthin from a phototrophic source and demonstrated commercial-scale manufacturing capability and performance over 18 months. SGI's natural astaxanthin has U.S. Food and Drug Administration regulatory approval for dietary supplement applications.

We looked at several companies to partner with on this important ingredient, said Jim Flatt, president of SGI's Genovia Bio. Avoca is the strong partner we sought who was capable of both processin
5/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/08 13:05